Cited 30 times in
Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이경원 | - |
dc.date.accessioned | 2016-02-19T11:08:31Z | - |
dc.date.available | 2016-02-19T11:08:31Z | - |
dc.date.issued | 2001 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/142489 | - |
dc.description.abstract | The trend of antimicrobial resistance of bacteria isolated from patients in 30 Korean hospitals in 1999 was analyzed with a particular attention to cefotaxime- or fluoroquinolone-resistant gram-negative bacilli, imipenem-resistant Pseudomonas aeruginosa, and vancomycin-resistant enterococci. Adequacy of susceptibility testing, and any change in the frequencies of isolated species were also analyzed. The results showed that only 20% and 30% of hospitals tested the piperacillin-tazobactam and cefoxitin susceptibility of Enterobacteriaceae, respectively, only 24% of hospitals the piperacillin-tazobactam susceptibility of P. aeruginosa, and 17% of hospitals the fusidic acid susceptibility of staphylococci. Among the isolates 26.3% were glucose-nonfermenting gram-negative bacilli, and 34.7% of Enterococcus were Enterococcus faecium. Slight decline of cefotaxime-resistance rate to 20% was noted in Klebsiella pneumoniae, while fluoroquinolone-resistance rate was 68% in Acinetobacter baumannii. The ceftazidime- and imipenem-resistance rates were 17% and 18%, respectively in P. aeruginosa. The vancomycin-resistance rate of E. faecium rose significantly to 15.1%, but the rates varied significantly depending on hospitals suggesting presence of different degree of selective pressure or nosocomial spread. In conclusion, the prevalence of imipenem-resistant P. aeruginosa and the increase of vancomycin-resistant E. faecium were the particularly worrisome phenomena observed in this study. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 262~270 | - |
dc.relation.isPartOf | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Anti-Bacterial Agents/pharmacology* | - |
dc.subject.MESH | Anti-Infective Agents/pharmacology* | - |
dc.subject.MESH | Cephalosporins/pharmacology* | - |
dc.subject.MESH | Drug Resistance, Microbial | - |
dc.subject.MESH | Enterobacteriaceae/drug effects | - |
dc.subject.MESH | Enterococcus/drug effects* | - |
dc.subject.MESH | Fluoroquinolones | - |
dc.subject.MESH | Gram-Negative Bacteria/drug effects* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Imipenem/pharmacology* | - |
dc.subject.MESH | Korea | - |
dc.subject.MESH | Microbial Sensitivity Tests | - |
dc.subject.MESH | Pseudomonas aeruginosa/drug effects | - |
dc.subject.MESH | Vancomycin Resistance* | - |
dc.title | Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Laboratory Medicine (진단검사의학) | - |
dc.contributor.googleauthor | K. Lee | - |
dc.contributor.googleauthor | H. S. Lee | - |
dc.contributor.googleauthor | S. J. Jang | - |
dc.contributor.googleauthor | A. J. Park | - |
dc.contributor.googleauthor | M. H. Lee | - |
dc.contributor.googleauthor | W. K. Song | - |
dc.contributor.googleauthor | Y. Chong | - |
dc.identifier.doi | 10.3346/jkms.2001.16.3.262 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02649 | - |
dc.relation.journalcode | J01517 | - |
dc.identifier.eissn | 1598-6357 | - |
dc.identifier.pmid | 11447969 | - |
dc.subject.keyword | Antimicrobial Drug Resistance in Korea | - |
dc.subject.keyword | Resistance Surveillance | - |
dc.subject.keyword | Vancomycin-Resistant Enterococci | - |
dc.subject.keyword | Imipenem-Resistant Pseudomonas | - |
dc.contributor.alternativeName | Lee, Kyung Won | - |
dc.contributor.affiliatedAuthor | Lee, Kyung Won | - |
dc.rights.accessRights | free | - |
dc.citation.volume | 16 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 262 | - |
dc.citation.endPage | 270 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, Vol.16(3) : 262-270, 2001 | - |
dc.identifier.rimsid | 31039 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.